Intravesical Therapy in the Management of Superficial Transitional Cell Carcinoma of the Bladder: The Experience of the EORTC GU Group

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1990.112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Single Centre Experience

Journal of Life Sciences
2016English

The Use of Intravesical BCG in Urothelial Carcinoma of the Bladder

ecancermedicalscience
Cancer ResearchOncology
2019English

The Expression and Clinical Significance of ZBTB7 in Transitional Cell Carcinoma of the Bladder

Oncology Letters
Cancer ResearchOncology
2017English

Potentially New and Innovative Treatments for Superficial, Muscle-Invasive, and Metastatic Transitional Cell Carcinoma (TCC) of the Bladder

The Internet Journal of Oncology
2005English

Intravesical Mitomycin Therapy for Stage T1 and Tis High-Grade Squamous Cell Carcinoma of the Bladder

Clinical Genitourinary Cancer
OncologyUrology
2014English

Cyclooxygenase-2 Expression in Invasive Transitional Cell Carcinoma of the Urinary Bladder

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

Spontaneous Intraperitoneal Rupture of the Bladder in Association With Transitional Cell Carcinoma.

Postgraduate Medical Journal
Medicine
1988English

Penile Metastasis From Primary Transitional Cell Carcinoma of the Bladder Sparing the Urethra

Canadian Urological Association Journal
Urology
2016English

HER2/neu Overexpression in the Development of Muscle-Invasive Transitional Cell Carcinoma of the Bladder

British Journal of Cancer
Cancer ResearchOncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy